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to be assessed: neuropathic symptoms, clinical examination, electrodiagnostic tests, quantitative sensory tests and autonomic function tests. With this in mind, the present study was conducted to determine the prevalence of diabetic neuropathy and its relation to known risk factors such as age, duration of diabetes and glycaemic control, and other potential risk factors, in a cross-sectional study involving over 3000 randomly selected insulin-dependent diabetic (IDDM) subjects, from 31 centres across Europe.
The aim of the neuropathy section of the EURO-DIAB IDDM Complications Study [7] was to measure the prevalence of diabetic peripheral neuropathy using measures that would be meaningful to clinicians, i. e. reasonable clinical and neurophysiological measures to be applied to large numbers of patients with a high degree of accuracy. Moreover, recognition of potential risk factors may provide possible pathogenetic mechanisms for the development of neuropathy.
Studying patients across a wide geographical area presented the opportunity to identify any regional differences which might give clues to environmental or other risk factors for the development of diabetic neuropathy. The opportunity was also taken to estimate the prevalence of diabetic impotence.
Subjects and methods
Three thousand two hundred and fifty patients were studied (1668 males and 1582 females, mean age ± SD 32.7 ± 10.2 years, mean duration of diabetes 14.7 ± 9.3 years, mean HbA 1c , 6.7 ± 1.9 %) [7] . Subjects with IDDM were randomly selected in a stratified manner from 31 diabetes clinic populations around Europe [7] . Patient selection criteria and methods have been described in detail in a recent publication [7] .
In all subjects HbA 1c , gamma glutamyl transferase (gamma GT), lipid profile and urinary albumin excretion rate were measured, the latter being derived from a single 24-h urine collection [7] . The daily intake of alcohol (g/day) was calculated from a detailed dietary record over 3 days. The presence and severity of diabetic retinopathy was assessed from centrally graded retinal photographs (two fields per eye) taken with a wide-angle camera [8] . Retinopathy was classified as background or proliferative. Proliferative retinopathy was defined as any new vessels, fibrous proliferations, pre-retinal haemorrhage, vitreous haemorrhage or photocoagulation scars.
Severe hypoglycaemia was defined as any episode severe enough to require the help of another person. Severe ketoacidosis was defined as an episode requiring hospital admission. Subjects were asked how many such episodes they had over the last 12 months.
Cardiovascular disease was defined either as the presence of a past history of cardiovascular disease (previous myocardial infarction, angina, coronary bypass grafting, stroke) or abnormal 12-lead electrocardiogram (classified by two observers according to the Minnesota Code).
The assessment of neuropathic symptoms and signs, measurement of vibration perception threshold and autonomic function constituted a protocol similar in detail to a number of protocols recently published [4, 5, 9] , in order to standardise an approach to the assessment and definition of diabetic neuropathy. For the sake of comparison with other similar protocols, details are provided of the various measures which were carried out. [10] . The presence of the following symptoms over the previous 6 months was ascertained: a) numbness or dead feeling in the feet; b) prickling sensation in the feet; c) deep or burning pains in the legs; d) unusual difficulty in climbing stairs; e) difficulty controlling the bladder and f) any trouble with nocturnal diarrhoea. In addition male patients were asked questions regarding impotence over the previous 6 months: a) any problems with sexual intercourse; b) any problems with obtaining an erection; c) any problems with sustaining an erection and d) spontaneous erections at night or in the morning.
Assessment of neuropathic symptoms
Neurological examination. Ankle and knee reflexes were performed, with reinforcement if necessary.
Vibration perception threshold assessment. This was measured by centrally calibrated biothesiometers (Biomedical, Newbury, Ohio, USA) [11] . Three readings were taken up to the nearest unit, on the right big toe and right medial malleolus, and their average used for analysis.
Autonomic function assessment. Autonomic function was assessed by testing two cardiovascular reflex responses: change in heart rate, and change in systolic blood pressure on standing up measured by a Hawksley random zero sphygmomanometer after resting horizontally for at least 5 min. The ratio of the longest electrocardiogram R-R interval between 28th and 32nd beats following standing to the shortest interval between the 13th and 17th beats was calculated by a single observer.
Definition of diabetic neuropathy. Diabetic neuropathy was diagnosed if abnormalities were found in two or more of the above described criteria, i. e. 1) the presence of one or more symptoms; 2) absence of two or more ankle or knee reflexes; 3) vibration perception threshold which was abnormal relating to age-related measures [12] and 4) abnormal autonomic function assessed using Ewing's definitons [13] of postural hypotension with a fall in systolic blood pressure of 30 mm Hg or more, and/or loss of heart rate variability (R-R ratio < 1).
Statistical analysis
Rates of neuropathy were directly standardised to the age, duration of diabetes and HbA 1c distributions of the whole sample. To assess the association between neuropathy and potential risk factors, continuous variables were grouped into quartiles and standardised relative risks of neuropathy were calculated, comparing the standardised rates of neuropathy in each quartile relative to that of the lowest quartile. For other diabetic complications standardised relative risks of neuropathy were calculated for those with complications relative to those without, and for smoking, relative risk of neuropathy was calculated for current smokers and ex-smokers relative to nonsmokers. Differences and trends in standardised relative risk were assessed using the extended Mantel Haenszel chi-square test. Backward stepwise logistics regression was used to assess the independent effect of significant risk factors on neuropathy and variables entered into the initial model were those having a significant association with neuropathy (p < 0.05) in previous analysis. The criteria for a risk factor to leave the model was p > 0.05. All analyses including serum triglyceride level excluded patients that were non-fasting, and because this resulted in skewed distribution, serum triglyceride level was log transformed for the regression analysis. Standardised relative risks were calculated, for a continuous variable, as the relative risk of neuropathy associated with an increase of one standard deviation. For a categorical variable it was the risk of neuropathy associated with the presence of the risk factor relative to the risk when it was absent.
Results
The overall prevalence of diabetic peripheral neuropathy was 28 %, with no difference according to sex. Figure 1 shows the prevalence of diabetic peripheral neuropathy in each centre. Although five centres had prevalences in excess of 35 %, there were no significant differences in the prevalence of neuropathy between the other centres. The following parameters were observed to see if there were significant associations with diabetic neuropathy:
Age, duration of diabetes and glycaemic control (Table 1). There were significant trends in the prevalence of diabetic peripheral neuropathy with increasing age (p < 0.05), duration of diabetes (p < 0.001) and HbA 1c (p < 0.001). Adjustments were made for age, duration of diabetes and HbA 1c as appropriate, as shown in Table 1 . Age at diagnosis of IDDM was not related to the prevalence of neuropathy.
Height, weight, body mass index, blood pressure and smoking (Table 2 ). Significant trends of increasing prevalence of diabetic peripheral neuropathy were only observed with increasing height (p < 0.01) and diastolic blood pressure (p < 0.05) when data was adjusted for age, duration of diabetes and HbA 1c . Current smoking status was also significantly associated with the prevalence of diabetic neuropathy (p < 0.001). (Table 3) . Although significant trends in increasing prevalence of diabetic neuropathy were observed with an increase in lipid and lipoprotein levels, only reduced HDL-cholesterol (p < 0.001) and raised fasting triglyceride (p < 0.001) levels were found to have significant associations with neuropathy when the data were adjusted for age, duration of diabetes and HbA 1c .
Lipids and lipoproteins
Acute diabetic complications (Fig. 2) . Only the presence of severe ketoacidocis was related to an increase in the relative risk of diabetic neuropathy (p < 0.001).
Chronic diabetic complications (Fig. 3) . Significant association was found between the prevalence of diabetic neuropathy and the presence of cardiovascular disease (p < 0.05). There was also a significant (p < 0.01) trend in the increase in the relative risk for the presence of diabetic neuropathy with an increase in the progression of both retinopathy and albumin excretion.
Alcohol consumption. There was no significant association between alcohol consumption and diabetic neuropathy. However, an increase in alcohol intake did relate to autonomic dysfunction (p < 0.01), absence of leg reflexes (p < 0.01) and a rise in gamma GT.
Impotence. A wide range of responses between study centres led to rather unsatisfactory data in this particular part of the study (problems with intercourse, 2-35 %; problems with erection, 3-85 %; problems sustaining erection, 2-83 %; presence of spontaneous morning erections, 23-84 %).
Multivariate analysis (Table 4 ). Multivariate analysis showed that other than age, duration of diabetes and HbA 1c , weight, current smoking, severe ketoacidosis, macroalbuminuria, background and proliferative retinopathy were found to be independent risk factors for neuropathy. When the analysis was repeated to include serum triglyceride level using fasting patients only, independent risk factors for neuropathy were age, duration of diabetes, HbA 1c , height, severe ketoacidosis, background and proliferative retinopathy and serum triglyceride level.
Discussion
The neurological analysis of subjects in the EURO-DIAB study represents one of the largest bodies of data concerning IDDM. It must be stressed that this study used subjects selected from well-established hospital-based diabetes clinics and gives no information concerning people in the wider community and those with non-insulin-dependent diabetes. The methodology for defining diabetic neuropathy in this study is very close to other protocols [4, 5, 9] which attempt to standardise the definition and it is suggested that since the described protocol in this EURODIAB IDDM Complications Study has been used around Europe, this could be taken as a reasonable standard for epidemiological European studies in the future. Using the definition of diabetic neuropathy described in the Methods section, 28 % of subjects have neuropathy, a frequency similar to that found in other studies [2, 4, 9] , suggesting that neurological assessment in such protocols has become fairly well standardised. Even in some recent population-based studies [14] [15] [16] [17] , the reported prevalence rates for neuropathy are similar to those in the present study. One such study reported that about 20 % of diabetic patients had symptomatic neuropathy; however, about 50 % were found to have objective evidence of diabetic polyneuropathy [17] . Our results confirm the well-established correlations between the prevalence of neuropathy and age [9, [18] [19] [20] , duration of diabetes [9, [18] [19] [20] [21] , and metabolic control [9, 20, 21] . Significant associations have also been reported with height [5, 22, 23] , cigarette smoking [9] , the presence of retinopathy [9, 21] , both background and proliferative, and reduced levels of HDL-cholesterol [9] .
However, some new associations of interest have been identified. The association with microalbuminuria is of potential importance and has not been previously described. This of course may simply reflect a general association with advanced disease. On the other hand it may be used to support the microvascular hypothesis in the pathogenesis of diabetic neuropathy [24] [25] [26] [27] [28] in that microalbuminuria, as a marker for early nephropathy, has undoubted microvascular aetiology. Moreover, there has recently been interest in the observation that the state of the autonomic nervous system relates to renal dysfunction, and it has been suggested that this could be due to autonomic neuropathy-induced impairment of renal blood flow [29, 30] . This observation is interesting and merits further research.
The strong association observed between neuropathy and severe ketoacidosis has also not been previously described. This may provide further evidence for the role of microvascular damage in the pathogenesis of neuropathy. It is known that severe microvascular abnormalities occur in the brain and peripheral nerves of those dying in diabetic ketoacidosis [31] . This consists primarily of disseminated intravascular coagulation with the deposition of coagulation breakdown products within the vessel lumen and the presence of layering of fibrin on the endothelial surface with, at times, disruption and exudation into the vessel wall itself. One therefore speculates whether the thickened layered appearance of the sural nerve capillary in neuropathy [32] is related to successive "intravascular insults" occurring during episodes of poor metabolic control. Since all these associations have been adjusted for age, duration of diabetes and metabolic control, a reduced level of HDL-cholesterol and an elevated level of fasting triglyceride level in association with neuropathy is of interest. Schwann cell lipid metabolism has been found to be abnormal [33] , and as a previous study has also reported a significant association of diabetic neuropathy with lower HDL-cholesterol levels [9] , this may reflect a blood marker of the pathological changes in the myelin structure of nerve. The significant association observed between neuropathy and cigarette smoking may at least in part be secondary to the vascular effects of the latter, as there has been increasing evidence of the importance of microvascular factors in the pathogenesis of diabetic neuropathy [24] [25] [26] [27] [28] .
Estimates of peripheral nerve dysfunction in the EURODIAB IDDM Complications Study should contribute to the understanding of the pathogenesis of diabetic neuropathy. The strong association of neuropathy with retinopathy, microalbuminuria and macroalbuminuria might be seen to lend support to the microvascular hypothesis [24] . The marked increase in the prevalence of neuropathy in a few centres compared to the majority was mainly felt to be due to variations in the technique of neurological and neurophysiological examination, although centrally calibrated biothesiometers were used and an attempt was made to standardise the method of autonomic function testing by visiting all the participating centres. It is also possible that differences in the referral pattern of diabetic patients to hospital-based specialists may be another factor, in that while in some countries all patients with IDDM are followed at hospitals, in other countries only those who can afford it or those with complications are followed in hospitals. However, there was remarkable similarity in the prevalence of neuropathy between most centres, and indeed with other previous studies. In some ways it was disappointing that no geographical differences were observed, for this might have led to identification of environmental factors likely to be associated with nerve damage. The various associations reported in the present study were reproduced when either abnormal vibration perception threshold alone or both abnormal vibration perception threshold and autonomic dysfunction were used to define the presence of neuropathy, but not when autonomic dysfunction was used as the sole criterion for the presence of peripheral neuropathy.
The role of alcohol in the development of diabetic neuropathy has been questioned for many decades. The association of leg-reflex change and autonomic dysfunction with alcohol consumption in the absence of overall association with total neuropathy score does not allow any useful conclusion. As ever, the unreliability of self-reporting of alcohol intake over a short period of time may well be the major reason for lack of a significant association.
The range of responses given to our various questions regarding impotence varied enormously among centres, from 2 to 85 %. The similarity of patterns of answers in some centres suggests that cultural and personal attitudes did not allow patients and their doctors to communicate in such a way that the true prevalence could be ascertained. This might indicate that in some centres it is not possible for patients with impotence to discuss their problem, and hence they will not be offered help or treatment. Strategies should therefore be developed to allow all men with diabetic impotence and their partners to raise this topic and receive help. For the future, studies of a fundamental nature will be required to allow an understanding of the pathogenesis of diabetic neuropathy. However, this large study has identified important potential risk factors for diabetic neuropathy. Examination of these patients in the future may lead to identification of factors which have led to the development of neuropathy or the progress of established neuropathy. This is clearly important, as risk reduction strategies may then be developed [9] . 
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